EUVIMEDEUVIMED entdecken
Crossref

Journal club: JAK inhibitors and safety

Angel Rosell Diaz, Tassilo Dege, Inès Chircop, Victoire Reynaud, Niamh Byrne, Am Lé, Paloma Garcia-Piqueras

European Journal of Dermatology · 2024

DOI: 10.1684/ejd.2024.4716 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2024. Verfasst von Angel Rosell Diaz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain. Hauptthemen laut MEDLINE: Janus Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BackgroundPalmoplantar keratoderma (PPK) is a group of ­disorders with genetic and phenotypic heterogeneity featuring skin thickening of the palms and soles. More than 60 genes involved in various biological processes are implicated in PPK. PIK3CA is an oncogene encoding p110α, and its somatic variants contribute to a spectrum of congenital overgrowth disorders, including epidermal nevi (EN).ObjectivesTo identify the genetic basis and elucidate the pathogenesis of a patient with unilateral focal PPK.Materials & MethodsWhole-exome sequencing and Sanger sequencing combined with laser capture microdissection (LCM) were performed on genomic DNA extracted from the patient’s peripheral blood and skin lesion. Skin biopsies were taken from the lesion of the patient and normal controls for immunofluorescence. Molecular docking was performed using Alphafold2-multimer.ResultsA three-year-old girl presented with unilateral focal PPK with an identified missense ­variant (c.3140A>G, p.His1047Arg) in PIK3CA from affected tissue. This variant only existed in the lesional epidermis. Elevated PI3K/AKT/mTOR signalling in the affected epidermis and an increased number of Ki67-positive keratinocytes were demonstrated. Molecular docking indicated instability of the p110α-p85α dimer caused by the PIK3CA His1047Arg variant.ConclusionWe describe the first PPK case associated with a variant in PIK3CA, which expands the spectrum of PIK3CA-related disorders. Our study further underscores the importance of the PI3K/AKT/mTOR pathway in the homeostasis of skin keratinization.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Janus Kinase InhibitorsHumansPsoriasisPyrimidinesPyrazolesPiperidinesNitriles

Substanzen

Janus Kinase InhibitorsPyrimidinestofacitinibPyrazolesruxolitinibPiperidinesNitriles

Autor:innen und Institutionen

  • Department of Dermatology, Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany.
  • CIRI, Centre International de Recherche en Infectiologie, (Team Epidermal Immunity and Allergy); INSERM, U1111; Univ Lyon; Université de Lyon 1; Ecole Normale Supérieure de Lyon; CNRS, UMR 5308, Lyon, France, Department…
  • Department of Dermatology Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, United Kingdom.
  • Department of Dermatology, Centro Hospitalar Universitário do Porto, Porto, Portugal.
  • Department of Dermatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.

Zitieren

APA

Diaz, A. R., Dege, T., Chircop, I., Reynaud, V., Byrne, N., Lé, A., & Garcia-Piqueras, P. (2024). Journal club: JAK inhibitors and safety. European Journal of Dermatology. https://doi.org/10.1684/ejd.2024.4716

Vancouver

Diaz AR, Dege T, Chircop I, Reynaud V, Byrne N, Lé A, et al. Journal club: JAK inhibitors and safety. European Journal of Dermatology. 2024. doi:10.1684/ejd.2024.4716

BibTeX
@article{Diaz2024,
  author = {Diaz, Angel Rosell and Dege, Tassilo and Chircop, Inès and Reynaud, Victoire and Byrne, Niamh and Lé, Am and Garcia-Piqueras, Paloma},
  title = {Journal club: JAK inhibitors and safety},
  journal = {European Journal of Dermatology},
  year = {2024},
  doi = {10.1684/ejd.2024.4716}
}
Kostenlos starten →